BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 32144458)

  • 1. Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.
    Tordjman M; Mali R; Madelin G; Prabhu V; Kang SK
    Eur Radiol; 2020 Jul; 30(7):4023-4038. PubMed ID: 32144458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement.
    Paschall AK; Mirmomen SM; Symons R; Pourmorteza A; Gautam R; Sahai A; Dwyer AJ; Merino MJ; Metwalli AR; Linehan WM; Malayeri AA
    Abdom Radiol (NY); 2018 Sep; 43(9):2424-2430. PubMed ID: 29520425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI.
    Li A; Xing W; Li H; Hu Y; Hu D; Li Z; Kamel IR
    AJR Am J Roentgenol; 2018 Sep; 211(3):614-623. PubMed ID: 29812980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Differentiation of Minimal Fat Angiomyolipoma from Clear Cell Renal Cell Carcinoma.
    Li H; Li A; Zhu H; Hu Y; Li J; Xia L; Hu D; Kamel IR; Li Z
    Acad Radiol; 2019 May; 26(5):632-639. PubMed ID: 30087067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic utility of diffusion weighted MRI imaging and ADC ratio to distinguish benign from malignant renal masses: sorting the kittens from the tigers.
    de Silva S; Lockhart KR; Aslan P; Nash P; Hutton A; Malouf D; Lee D; Cozzi P; MacLean F; Thompson J
    BMC Urol; 2021 Apr; 21(1):67. PubMed ID: 33888122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.
    Mytsyk Y; Dutka I; Borys Y; Komnatska I; Shatynska-Mytsyk I; Farooqi AA; Gazdikova K; Caprnda M; Rodrigo L; Kruzliak P
    Int Urol Nephrol; 2017 Feb; 49(2):215-224. PubMed ID: 27853915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Biexponential and Monoexponential Model of Diffusion-Weighted Imaging for Distinguishing between Common Renal Cell Carcinoma and Fat Poor Angiomyolipoma.
    Ding Y; Zeng M; Rao S; Chen C; Fu C; Zhou J
    Korean J Radiol; 2016; 17(6):853-863. PubMed ID: 27833401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoexponential, biexponential, and stretched exponential diffusion-weighted imaging models: Quantitative biomarkers for differentiating renal clear cell carcinoma and minimal fat angiomyolipoma.
    Li H; Liang L; Li A; Hu Y; Hu D; Li Z; Kamel IR
    J Magn Reson Imaging; 2017 Jul; 46(1):240-247. PubMed ID: 27859853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
    Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
    AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small (< 4 cm) Renal Tumors With Predominantly Low Signal Intensity on T2-Weighted Images: Differentiation of Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma.
    Park JJ; Kim CK
    AJR Am J Roentgenol; 2017 Jan; 208(1):124-130. PubMed ID: 27824487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney tumor diffusion-weighted magnetic resonance imaging derived ADC histogram parameters combined with patient characteristics and tumor volume to discriminate oncocytoma from renal cell carcinoma.
    van Oostenbrugge TJ; Spenkelink IM; Bokacheva L; Rusinek H; van Amerongen MJ; Langenhuijsen JF; Mulders PFA; Fütterer JJ
    Eur J Radiol; 2021 Dec; 145():110013. PubMed ID: 34768055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of MRI for Detection of Papillary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Chiarello MA; Mali RD; Kang SK
    AJR Am J Roentgenol; 2018 Oct; 211(4):812-821. PubMed ID: 30063398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Angiomyolipoma With Minimal Fat from Clear Cell Renal Cell Carcinoma Using Non-contrast Multiparametric Magnetic Resonance Imaging.
    Jomoto W; Takaki H; Yamamoto S; Kanematsu A; Igeta M; Hirota S; Yamakado K
    In Vivo; 2022; 36(6):2790-2799. PubMed ID: 36309367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.
    Zhong Y; Wang H; Shen Y; Guo A; Wang J; Kang S; Ma L; Pan J; Ye H
    Eur Radiol; 2017 Dec; 27(12):4913-4922. PubMed ID: 28631081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of the small renal masses: role of the apparent diffusion coefficient of the diffusion-weighted MRI.
    Mytsyk Y; Dutka I; Yuriy B; Maksymovych I; Caprnda M; Gazdikova K; Rodrigo L; Kruzliak P; Illjuk P; Farooqi AA
    Int Urol Nephrol; 2018 Feb; 50(2):197-204. PubMed ID: 29230706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging using 3.0 T MRI as a possible biomarker of renal tumors.
    Mirka H; Korcakova E; Kastner J; Hora M; Hes O; Hosek P; Ferda J
    Anticancer Res; 2015 Apr; 35(4):2351-7. PubMed ID: 25862900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of renal lesions by diffusion-weighted magnetic resonance imaging applying intravoxel incoherent motion-derived parameters--initial experience.
    Rheinheimer S; Stieltjes B; Schneider F; Simon D; Pahernik S; Kauczor HU; Hallscheidt P
    Eur J Radiol; 2012 Mar; 81(3):e310-6. PubMed ID: 22104090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.